Astrana Health Inc (ASTH) has a current Price-to-Book (P/B) ratio of 1.61. Compared to its 3-year average P/B ratio of 2.61, the current P/B ratio is approximately -38.53% higher. Relative to its 5-year average P/B ratio of 3.67, the current P/B ratio is about -56.28% higher. Astrana Health Inc (ASTH) has a Forward Free Cash Flow (FCF) yield of approximately 7.67%. Compared to its 3-year average FCF yield of 4.22%, the current FCF yield is approximately 81.74% lower. Relative to its 5-year average FCF yield of 3.29%, the current FCF yield is about 132.95% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ASTH competitors is 1.43, providing a benchmark for relative valuation. Astrana Health Inc Corp (ASTH.O) exhibits a P/S ratio of 0.33, which is -76.91% above the industry average. Given its robust revenue growth of 99.71%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ASTH increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ASTH in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ASTH currently overvalued or undervalued?

What is Astrana Health Inc (ASTH) fair value?

ASTH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Astrana Health Inc (ASTH) is between 13.28 to 33.74 according to relative valuation method.

How does ASTH's valuation metrics compare to the industry average?

The average P/S ratio for ASTH's competitors is 1.43, providing a benchmark for relative valuation. Astrana Health Inc Corp (ASTH) exhibits a P/S ratio of 0.33, which is -76.91% above the industry average. Given its robust revenue growth of 99.71%, this premium appears sustainable.

What is the current P/B ratio for Astrana Health Inc (ASTH) as of Mar 02 2026?

As of Mar 02 2026, Astrana Health Inc (ASTH) has a P/B ratio of 1.61. This indicates that the market values ASTH at 1.61 times its book value.

What is the current FCF Yield for Astrana Health Inc (ASTH) as of Mar 02 2026?

As of Mar 02 2026, Astrana Health Inc (ASTH) has a FCF Yield of 7.67%. This means that for every dollar of Astrana Health Inc's market capitalization, the company generates 7.67 cents in free cash flow.

What is the current Forward P/E ratio for Astrana Health Inc (ASTH) as of Mar 02 2026?

As of Mar 02 2026, Astrana Health Inc (ASTH) has a Forward P/E ratio of 30.44. This means the market is willing to pay $30.44 for every dollar of Astrana Health Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Astrana Health Inc (ASTH) as of Mar 02 2026?

As of Mar 02 2026, Astrana Health Inc (ASTH) has a Forward P/S ratio of 0.33. This means the market is valuing ASTH at $0.33 for every dollar of expected revenue over the next 12 months.

ASTH Valuation